Tikoo A - Search Results

1

p190-A, a human tumor suppressor gene, maps to the chromosomal region 19q13.3 that is reportedly deleted in some gliomas.

Tikoo A, Czekay S, Viars C, White S, Heath JK, Arden K, Maruta H. Tikoo A, et al. Gene. 2000 Oct 17;257(1):23-31. doi: 10.1016/s0378-1119(00)00387-5. Gene. 2000. PMID: 11054565

2

The GTPase and Rho GAP domains of p190, a tumor suppressor protein that binds the M(r) 120,000 Ras GAP, independently function as anti-Ras tumor suppressors.

Wang DZ, Nur-E-Kamal MS, Tikoo A, Montague W, Maruta H. Wang DZ, et al. Among authors: tikoo a. Cancer Res. 1997 Jun 15;57(12):2478-84. Cancer Res. 1997. PMID: 9192829

3

Treatment of Ras-induced cancers by the F-actin cappers tensin and chaetoglobosin K, in combination with the caspase-1 inhibitor N1445.

Tikoo A, Cutler H, Lo SH, Chen LB, Maruta H. Tikoo A, et al. Cancer J Sci Am. 1999 Sep-Oct;5(5):293-300. Cancer J Sci Am. 1999. PMID: 10526670

4

An anti-Ras function of neurofibromatosis type 2 gene product (NF2/Merlin).

Tikoo A, Varga M, Ramesh V, Gusella J, Maruta H. Tikoo A, et al. J Biol Chem. 1994 Sep 23;269(38):23387-90. J Biol Chem. 1994. PMID: 8089100 Free article.

5

G proteins, phosphoinositides, and actin-cytoskeleton in the control of cancer growth.

Maruta H, He H, Tikoo A, Vuong T, Nur-E-Kamal M. Maruta H, et al. Among authors: tikoo a. Microsc Res Tech. 1999 Oct 1;47(1):61-6. doi: 10.1002/(SICI)1097-0029(19991001)47:1<61::AID-JEMT6>3.0.CO;2-Y. Microsc Res Tech. 1999. PMID: 10506762 Review.

6

Cytoskeletal tumor suppressors that block oncogenic RAS signaling.

Maruta H, He H, Tikoo A, Nur-e-Kamal M. Maruta H, et al. Among authors: tikoo a. Ann N Y Acad Sci. 1999;886:48-57. doi: 10.1111/j.1749-6632.1999.tb09399.x. Ann N Y Acad Sci. 1999. PMID: 10667202 Review.

7

The minimal fragments of c-Raf-1 and NF1 that can suppress v-Ha-Ras-induced malignant phenotype.

Fridman M, Tikoo A, Varga M, Murphy A, Nur-E-Kamal MS, Maruta H. Fridman M, et al. Among authors: tikoo a. J Biol Chem. 1994 Dec 2;269(48):30105-8. J Biol Chem. 1994. PMID: 7982912 Free article.

8

A clue to the therapy of neurofibromatosis type 2: NF2/merlin is a PAK1 inhibitor.

Hirokawa Y, Tikoo A, Huynh J, Utermark T, Hanemann CO, Giovannini M, Xiao GH, Testa JR, Wood J, Maruta H. Hirokawa Y, et al. Among authors: tikoo a. Cancer J. 2004 Jan-Feb;10(1):20-6. doi: 10.1097/00130404-200401000-00006. Cancer J. 2004. PMID: 15000491

9

The anti-RAS cancer drug MKT-077 is an F-actin cross-linker.

Maruta H, Tikoo A, Shakri R, Shishido T. Maruta H, et al. Among authors: tikoo a. Ann N Y Acad Sci. 1999;886:283-4. doi: 10.1111/j.1749-6632.1999.tb09437.x. Ann N Y Acad Sci. 1999. PMID: 10667240 No abstract available.

10

Treatment of ras-induced cancers by the F-actin-bundling drug MKT-077.

Tikoo A, Shakri R, Connolly L, Hirokawa Y, Shishido T, Bowers B, Ye LH, Kohama K, Simpson RJ, Maruta H. Tikoo A, et al. Cancer J. 2000 May-Jun;6(3):162-8. Cancer J. 2000. PMID: 10882332

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters